Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication.
- Author:
Yu Mi LEE
1
;
Kyu Chan HUH
;
Soon Man YOON
;
Byung Ik JANG
;
Jeong Eun SHIN
;
Hoon Sup KOO
;
Yunho JUNG
;
Sae Hee KIM
;
Hee Seok MOON
;
Seung Woo LEE
Author Information
- Publication Type:Original Article ; Multicenter Study
- Keywords: Enterocolitis; pseudomembranous; Clostridium difficile; Tuberculosis; Rifampin
- MeSH: Adult; Aged; Aged, 80 and over; Anti-Infective Agents/therapeutic use; Antibiotics, Antitubercular/*adverse effects; *Clostridium difficile; Enterocolitis, Pseudomembranous/chemically induced/drug therapy/*epidemiology; Female; Humans; Incidence; Male; Metronidazole/therapeutic use; Middle Aged; Retrospective Studies; Rifampin/*adverse effects; Treatment Outcome; Tuberculosis/*drug therapy
- From:Gut and Liver 2016;10(2):250-254
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND/AIMS: To determine the incidence and clinical characteristics of tuberculosis (TB) medication-associated Clostridium difficile infection. METHODS: This multicenter study included patients from eight tertiary hospitals enrolled from 2008 to 2013. A retrospective analysis was conducted to identify the clinical features of C. difficile infection in patients who received TB medication. RESULTS: C. difficile infection developed in 54 of the 19,080 patients prescribed TB medication, representing a total incidence of infection of 2.83 cases per 1,000 adults. Fifty-one of the 54 patients (94.4%) were treated with rifampin. The patients were usually treated with oral metronidazole, which produced improvement in 47 of the 54 patients (87%). Twenty-three patients clinically improved with continuous rifampin therapy for C. difficile infection. There were no significant differences in improvement between patients treated continuously (n=21) and patients in whom treatment was discontinued (n=26). CONCLUSIONS: The incidence of C. difficile infection after TB medication was not low considering the relatively low TB medication dosage compared to other antibiotics. It may not be always necessary to discontinue TB medication. Instead, decisions concerning discontinuation of TB medication should be based on TB status.
